Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 1
R&D Momentum
48/100
Pipeline Velocity
30/100
Trial Completion Rate
63/100
Pipeline Concentration
100/100
Pipeline Freshness
89/100
Activity
Last 14 days
Dose-Response Effects of a Brief Audio-Guided Mindfulness Intervention for Acute Pain While Awaiting Orthopedic Care
Does Patient Testimonial Improve the Pain Relief Derived From a Brief Behavioral Intervention Delivered to Patients Experiencing Pain in a Clinic Waiting Room
Mindfulness Intervention for Individuals With HIV and Chronic Pain
Associations Between Body Composition, Energy Availability, and Lifestyle Factors in Reserve Officer Training Corps Cadets
Translating Behavioral Economics Strategies to Culturally Tailor a Mobile Health Mindfulness Intervention to Reduce Risky Drinking Behaviors in Emerging Adult College Student Students
Body Composition and Characteristics of Performance in Collegiate Cheerleaders and Dancers
A Scalable Nutrition Intervention to Improve Gut and Brain Health in Underserved Rural Older Adults With and Without Mild Cognitive Impairment
An Investigation of a Brief Psycho-Social Computerized Intervention Targeting the Error-Related Negativity and Balance N1 in Anxious Children
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)